- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Platelet-Derived Growth Factor in United States
Total 60 results
-
University of MichiganCompletedGingival Recession | Platelet Derived Growth FactorUnited States
-
University of California, Los AngelesApplied BioClinical Inc.CompletedCognitive Function | Affect | Brain-derived Neurotrophic Factor (BDNF)United States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHealthy | Nitric Oxide | Endothelium-Derived Relaxing FactorUnited States
-
IpsenCompletedGrowth Disorders | Insulin-Like Growth Factor-1 DeficiencyUnited States
-
University of ReadingTufts University; California Walnut CommissionCompletedCognitive Change | Inflammatory Response | Mood | Satiety | Brain Derived Neurotrophic Factor LevelUnited Kingdom
-
Janssen Research & Development, LLCCompletedUrothelial Cancer | Receptors, Fibroblast Growth FactorUnited States, Italy, Belgium, United Kingdom, Japan, Turkey, Brazil, Ukraine, Spain, Russian Federation, Israel, France, Germany, Argentina
-
Massachusetts General HospitalGlaxoSmithKlineTerminatedCoronary Artery Bypass Graft Surgery | Presence of Heparin/Platelet Factor 4 AntibodyUnited States
-
Wright State UniversityRecruitingAging | UVB Phototherapy Burn | Insulin-like Growth Factor 1United States
-
Azitra Inc.SuspendedPapulopustular Rosacea | Epidermal Growth FactorUnited States
-
Vanderbilt University Medical CenterCompletedNormal Pressure HydrocephalusUnited States
-
IpsenTerminatedPrimary Insulin-like Growth Factor-1 DeficiencyUnited States
-
IpsenCompletedGrowth Disorders | Insulin-Like Growth Factor-1 DeficiencyUnited States
-
University of ChicagoNot yet recruitingBreast Cancer | HER2-positive Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastUnited States
-
Dana-Farber Cancer InstitutePfizerCompletedHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone Receptor (HR)-Positive Breast CancerUnited States
-
Dana-Farber Cancer InstituteEisai Inc.Active, not recruitingInflammatory Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastUnited States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer InstituteTerminatedBreast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Positive Breast Cancer | Node-negative Breast CancerUnited States
-
Georgetown UniversityPfizerActive, not recruitingMetastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone Receptor Positive Breast CancerUnited States
-
State University of New York at BuffaloAmerican Egg BoardCompletedObesity | Metabolic Syndrome | Cardiovascular Risk Factor | Food Allergy | Growth & Development | Cognitive Developmental DelayUnited States
-
IpsenTerminatedrhGH and rhIGF-1 Combination Therapy in Children With Short Stature Associated With IGF-1 DeficiencyInsulin-like Growth Factor-1 DeficiencyUnited States
-
Reshma L. Mahtani, D.O.Gilead SciencesNot yet recruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Hormone-receptor-positive Breast Cancer | Human Epidermal Growth Factor 2 Low Breast CancerUnited States
-
Jonsson Comprehensive Cancer CenterNational Center for Advancing Translational Sciences (NCATS)RecruitingGlioblastoma Multiforme | Epidermal Growth Factor Receptor | Glycolytic IndexUnited States
-
Dana-Farber Cancer InstituteAstellas Pharma IncTerminatedNon-Small Cell Lung Cancer | Epidermal Growth Factor ReceptorUnited States
-
AmgenRecruitingSolid TumorsCanada, Korea, Republic of, Australia, Netherlands, United States, Israel, Austria, Spain, United Kingdom, France, Belgium, Japan, Czechia, Hungary, Poland, Brazil, Italy, Argentina, Denmark, Greece, Mexico, Switzerland, Romania, Finland and more
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedAdvanced Breast Cancer | HER2 Amplified | Human Epidermal Growth Factor Receptor 2 (HER2)United States, Belgium, Canada, Italy, Spain, United Kingdom
-
Daiichi SankyoAvailableEpidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung CancerUnited States
-
Montefiore Medical CenterAlbert Einstein College of Medicine; Deciphera Pharmaceuticals LLCTerminatedBreast Cancer | Stage IV Breast Cancer | Recurrent Breast Carcinoma | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Breast AdenocarcinomaUnited States
-
Johns Hopkins Bloomberg School of Public HealthJohns Hopkins University; University of Maryland; University of California, San... and other collaboratorsRecruitingThrombocytopenia | Severe MalariaUnited States, Zambia
-
University of ArizonaNational Cancer Institute (NCI)CompletedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastUnited States
-
MedSIRPfizerCompletedBreast Cancer | Advanced Breast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastSpain, Germany, France, United Kingdom, Italy, Slovenia
-
Northwestern UniversityNational Cancer Institute (NCI); Boehringer Ingelheim; Robert H. Lurie Cancer...Active, not recruitingRecurrent Adult Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A | Fibroblast Growth Factor Basic Form Measurement | FLT3 Internal Tandem DuplicationUnited States
-
Oana Danciu, MDPfizer; Big Ten Cancer Research ConsortiumActive, not recruitingMetastatic Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive TumorUnited States
-
University of UtahActive, not recruitingNon-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor (Disorder)United States
-
iOMEDICO AGPfizerCompletedBreast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastGermany
-
Janssen Research & Development, LLCRecruitingUrinary Bladder Neoplasms | Receptors, Fibroblast Growth FactorKorea, Republic of, United States, Germany, Spain, Netherlands
-
Astellas Pharma Global Development, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC) | Epidermal Growth Factor Receptor (EGFR) MutationsUnited States
-
Merck KGaA, Darmstadt, GermanyCompletedEpidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal CancerSweden, Australia, Brazil, Bulgaria, France, Italy, Korea, Republic of, Russian Federation, South Africa, Spain, Turkey, United Kingdom, Germany, Hungary, Poland, Romania, Austria, Belgium, Finland, Netherlands, Slovakia, Greece, Ta... and more
-
University of ArizonaNational Cancer Institute (NCI); GlaxoSmithKlineTerminatedMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastUnited States
-
European Organisation for Research and Treatment...Active, not recruitingMalignant Neoplasm of Stomach | Malignant Neoplasm of Cardio-esophageal Junction of Stomach | Epidermal Growth Factor Receptor (EGFR) Protein OverexpressionSpain, Korea, Republic of, Singapore, Switzerland, Germany, United Kingdom, Italy, France, Estonia, Belgium, Netherlands, Norway, Portugal
-
Hoffmann-La RocheTerminatedEstrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast CancerCanada, United States, United Kingdom, Australia, Germany
-
CSL BehringCompletedBlood Coagulation Disorders | Blood Platelet Disorders | Hematologic Disease | Von Willebrand DiseaseUnited States
-
Astellas Pharma Global Development, Inc.CompletedNon-Small-Cell Lung Cancer (NSCLC) | Epidermal Growth Factor Receptor MutationsUnited States
-
American Thrombosis and Hemostasis NetworkSanofi; Pfizer; Genentech, Inc.; CSL Behring; Hemophilia of Georgia, Inc.; Hemab TherapeuticsRecruitingHemophilia | Thrombosis | Thrombophilia | Sickle Cell Disease | Thalassemia | Bleeding Disorder | Von Willebrand Diseases | Factor IX Deficiency | Connective Tissue Disorder | Factor VIII Deficiency | Hematologic Disorder | Rare Bleeding Disorder | Platelet DisorderUnited States
-
European Organisation for Research and Treatment...Hoffmann-La Roche; UNICANCER; Janssen Diagnostics, LLC; SUCCESSCompletedBreast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Circulating Tumor CellsFrance, Germany, Belgium, United Kingdom
-
Black Diamond Therapeutics, Inc.RecruitingNon-Small Cell Lung Cancer | NSCLC | Metastatic Lung Cancer | Metastatic Lung Non-Small Cell Carcinoma | EGF-R Positive Non-Small Cell Lung Cancer | Advanced Lung Carcinoma | EGFR-TKI Resistant Mutation | Advanced Non-Small Cell Squamous Lung Cancer | Epidermal Growth Factor Receptor C797S | Epidermal...Korea, Republic of, United States
-
Incyclix BioRecruitingBreast Cancer | Ovarian Cancer | Solid Tumor | Metastatic Cancer | Advanced Cancer | Breast Cancer Metastatic | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | CCNE1 AmplificationUnited States, Australia
-
Baylor College of MedicineShireActive, not recruiting
-
Antonio Giordano, MDCardiff OncologyRecruitingBreast Cancer | Metastatic Breast Cancer | Inflammatory Breast Cancer | Invasive Breast Cancer | Locally Advanced Breast Cancer | Unresectable Breast Carcinoma | HER2-negative Breast Cancer | Triple Negative Breast Cancer (TNBC) | Hormone Receptor Negative Breast Carcinoma | Hormone Receptor/Growth Factor...United States
-
Carey Anders, M.D.Seagen Inc.RecruitingAdvanced Breast Cancer | Brain Metastases | Human Epidermal Growth Factor 2 Positive Carcinoma of BreastUnited States
-
Taiho Oncology, Inc.RecruitingAdvanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) MutationsUnited States, Japan, Spain, Italy, France, Australia, Korea, Republic of, United Kingdom, Canada, Germany, Turkey, Hong Kong
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.TerminatedTriple Negative Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Negative Breast CancerUnited States